Amgen Inc. v. Hospira, Inc.
1:18-cv-01064
Overview
Parties
Defendant
Pfizer Inc. Operating Company
Represented By
14 Attorneys ListedPotter Anderson & Corroon LLP
1313 North Market Street, 6th Floor, Wilmington, DE 19801
Connolly Gallagher LLP
267 East Main Street, Newark, DE 19711
Connolly Gallagher LLP
1201 North Market Street, 20th Floor, Wilmington, DE 19801
Connolly Gallagher LLP
1201 North Market Street, 20th Floor, Wilmington, DE 19801
Hospira, Inc. Operating Company
Represented By
14 Attorneys ListedPotter Anderson & Corroon LLP
1313 North Market Street, 6th Floor, Wilmington, DE 19801
Connolly Gallagher LLP
267 East Main Street, Newark, DE 19711
Connolly Gallagher LLP
1201 North Market Street, 20th Floor, Wilmington, DE 19801
Connolly Gallagher LLP
1201 North Market Street, 20th Floor, Wilmington, DE 19801
Plaintiff
Amgen Manufacturing, Limited NPE (University / Research)
Represented By
19 Attorneys ListedRichards, Layton & Finger, PA
Richards, Layton & Finger, PA, One Rodney Square
Richards, Layton & Finger, PA
Richards, Layton & Finger, PA, One Rodney Square
Richards, Layton & Finger, PA
Richards, Layton & Finger, PA, One Rodney Square
Amgen Inc. Operating Company
Represented By
21 Attorneys ListedRichards, Layton & Finger, PA
Richards, Layton & Finger, PA, One Rodney Square
Richards, Layton & Finger, PA
Richards, Layton & Finger, PA, One Rodney Square
Richards, Layton & Finger, PA
Richards, Layton & Finger, PA, One Rodney Square
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 6 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | US 9,643,997 B2 Asserted | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 10,577,392 B2 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 11,407,784 B2 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 12,312,381 B2 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 22,047,709 P | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 8,940,878 B2 | US Continuation / Sibling | View Official Patent → |
Kashiv BioSciences, LLC v. Amgen Inc.
Amgen Inc. v. Hospira, Inc.
Patents Involved
There is a single patent involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US9643997
Capture purification processes for proteins expressed in a non-mammalian system
|
Filed: 2015-01-16
Issued: 2017-05-09
|
Active (8.2 yrs remaining)
Expires: 2035-01-16
|
Patent Enforceability & Injunction Risk Assessment
Active Threat — Patent is within enforceable statutory term. Patentee retains legal standing to seek permanent injunctive relief and exclusion orders.
Standard Statutory Term — No obviousness-type double patenting truncation noted.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).
Procedural Motions & Interlocutory Orders
Total Motions
102
Dispositive
31
Granted
2
Denied
3
Pending / Review
72
Motions by Category
Key Dispositive Motions & Rulings